Latest Pricing NewsRSS

11:35 EDT 25th March 2017 | BioPortfolio

#jobs #lifescience Senior Cost Accounting Analyst

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Cost Accounting Analyst .MA-Waltham, RESPONSIBILITIES: One of Kforce’s clients in Waltham, MA is searching for a Senior Cost Accounting Analyst. Essential Functions Include: Manage accounting close activities … Continue reading → Cet article #jobs #lif...

Insider Selling: Mylan (MYL) Major Shareholder Sells 44,000,000 Shares of Stock

Mylan major shareholder Laboratories Abbott sold 44,000,000 shares of the company's stock in a transaction that occurred on Thursday, March 23rd. The stock was sold at an average price of $41.60, for a total value of $1,830,400,000.00.

Medicare patients eligible to receive reimbursement for Dexcom system

Brian BerkAccording to Dexcom, its continuous glucose monitoring system is proven to significantly lower A1C levels resulting in lowered medical costs from diabetes complications (e.g., ER visits, seizures, etc.) and is now the only device approved for CGM for Medicare. read more

Electrosurgical Devices Global Market Forecast To 2020 [Updated: 29042015] Prices from USD $4500

Electro surgery deals with the interaction of electrons with tissue to achieve a desired clinical effect. Electrosurgical units ESU's are used for surgical cutting or to manage blood loss by causing coagulation homeostasis during surgery. The global electrosurgical devices market is divided into products, surgery and geography. The global electrosurgical devices products market is segmented into e...

Ampoules Market International Growth, Trends Analysis Report 2022 - ReportsnReports

PUNE, India, March 24, 2017 /PRNewswire/ -- Global Ampoules Market report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ampoules market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Complete report on Am...

How I'd Play Biotech Buyout Rumors

Click to view a price quote on FLXN. Click to research the Drugs industry.

Telit Communications Plc (TCM) Stock Rating Reaffirmed by Morgan Stanley

's stock had its "overweight" rating reiterated by Morgan Stanley in a research report issued on Wednesday. They currently have a GBX 350 price objective on the stock.

Immunomedics, Mylan Lead Biotech Movers

Click to view a price quote on IMMU. Click to research the Drugs industry.

Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk

Click to view a price quote on SAGE.

In the state with the highest medical debt, it’s the middle class who carries the burden

Nearly 40 percent of adults under 65 carry medical debt, and many of them are middle class. When they don't pay their bills, hospitals must eat the cost.

US pharmacy benefit firm suggests rebates are not driving drug price rises

Drug pricing has become a prominent political issue in recent years, and especially in the US. High prices for new drugs and continuous increases for older branded drugs (and even generic drugs) have generated negative publicity for drugmakers, and in some cases even official investigations. In response to this, pharmaceutical companies have begun to make pledges on prices. Several have suggested ...

Exxon, Thermo Fisher and 2 More Are Showing Red Flags

Click to view a price quote on XOM. Click to research the Energy industry.

Vetr Inc. Downgrades Teva Pharmaceutical Industries Ltd (TEVA) to Buy

They presently have a $36.12 price objective on the stock. Vetr 's price objective suggests a potential upside of 10.36% from the stock's previous close.

A Low-Cost, Heat-Stable Rotavirus Vaccine

Vaccine efficacy was 66.7% at preventing first-episode rotavirus gastroenteritis in Nigerian infants.

Bellicum Announces Pricing Of Public Offering Of Common Stock

  Life Sciences Jobs   ...

Telit Communications Plc (TCM) Insider Oozi Cats Purchases 242 Shares

Telit Communications Plc insider Oozi Cats bought 242 shares of Telit Communications Plc stock in a transaction dated Wednesday, March 22nd. The stock was acquired at an average price of GBX 316 per share, with a total value of A 764.72 .

VIDEO: How a physician can perform well in MIPS

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Michael Sherling, MD, MBA, discusses the components of the Merit-based Incentive Payment System, known as MIPS, and how a physician can perform well with it.Sherling, a board-certified dermatologist and co-founder of Modernizing Medicine, reported that there are three components that comprise MIPS sc...

STAT Plus: Spain’s antitrust watchdog probes drug makers over a pricing scheme

At issue is dual pricing, which drug makers use to fight parallel trade, but which wholesalers claim is unfair.

Leerink Swann Reaffirms "Outperform" Rating for Mylan

Several other research firms have also recently commented on MYL. Mizuho raised their price target on Mylan from $47.00 to $53.00 and gave the company a buy rating in a report on Monday, March 13th.

ICYMI: What the experts are saying about importation

Voices throughout the U.S. and Canadian health care systems have raised concerns about proposed large-scale drug importation schemes. Former government officials, pharmacy groups and experts have called attention to the potential dangers associated with these importation schemes, as well as the lack of cost savings for American patients. Here’s a l

Intra-articular high-molecular-weight hyaluronic acid most likely cost-effective for knee OA

Intra-articular high-molecular-weight hyaluronic acid had an 86% chance of being cost-effective when added to knee osteoarthritis care, according to recently published data. Job Hermans , MD, in the Department of Orthopedic Surgery at Erasmus MC University Medical Centre in The Netherlands, and colleagues randomized 156 secondary care patients with knee osteoarthritis (OA) to eithe...

NW Bio Has Closed On Its Registered Direct Offering Of $7.5 Million With Institutional Investors

BETHESDA, Md., March 23, 2017 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that yesterday it closed on the $7.5 million financing it announced last Friday, March 17, 2017. The Company sold to several institutional investors securities totaling 28,843,692...

La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla” or the “Company”), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced the pricing of an underwritten public offering of approximately 3.7 million shares of common stock, offered...

Health Care Vote Impacts Trump's Deal Maker Image

Click to view a price quote on CARA. Click to research the Drugs industry.

Sanofi Said to Be Near $1 Billion Deal for Flexion

Click to view a price quote on FLXN. Click to research the Drugs industry.

Quick Search

review and buy Pricing market research data and corporate reports here